These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8196925)

  • 1. Control of eyelid retraction associated with Graves' disease with botulinum A toxin.
    Biglan AW
    Ophthalmic Surg; 1994 Mar; 25(3):186-8. PubMed ID: 8196925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A in upper lid retraction of Graves' ophthalmopathy.
    Ebner R
    J Clin Neuroophthalmol; 1993 Dec; 13(4):258-61. PubMed ID: 8113438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemodenervation in treatment of upper eyelid retraction.
    Ozkan SB; Can D; Söylev MF; Arsan AK; Duman S
    Ophthalmologica; 1997; 211(6):387-90. PubMed ID: 9380360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levator palpebrae superioris muscle: MR evaluation of enlargement as a cause of upper eyelid retraction in Graves disease.
    Ohnishi T; Noguchi S; Murakami N; Nakahara H; Hoshi H; Jinnouchi S; Futami S; Nagamachi S; Watanabe K
    Radiology; 1993 Jul; 188(1):115-8. PubMed ID: 8511284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surgical treatment of lid retraction in Graves' ophthalmopathy].
    He YJ; Song GX
    Zhonghua Yan Ke Za Zhi; 1991 Nov; 27(6):356-7. PubMed ID: 1818827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transconjunctival Müller muscle recession with levator disinsertion for correction of eyelid retraction associated with thyroid-related orbitopathy.
    Elner VM; Hassan AS; Frueh BR
    Am J Ophthalmol; 2006 Jan; 141(1):233; author reply 233-4. PubMed ID: 16387028
    [No Abstract]   [Full Text] [Related]  

  • 7. Transconjunctival Müller muscle recession with levator disinsertion for correction of eyelid retraction associated with thyroid-related orbitopathy.
    Ben Simon GJ; Mansury AM; Schwarcz RM; Modjtahedi S; McCann JD; Goldberg RA
    Am J Ophthalmol; 2005 Jul; 140(1):94-9. PubMed ID: 15939390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enlargement of levator palpebrae superioris muscle fibers in Graves' ophthalmopathy.
    Small RG
    Ophthalmology; 1989 Apr; 96(4):424-30. PubMed ID: 2726172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction--a pilot study.
    Träisk F; Tallstedt L
    Acta Ophthalmol Scand; 2001 Dec; 79(6):585-8. PubMed ID: 11782224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum toxin for treatment of extraocular muscle disorders].
    BenEzra D
    Harefuah; 1988 Feb; 114(3):123-4. PubMed ID: 3350429
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationships between eyelid position and levator-superior rectus complex and inferior rectus muscle in patients with Graves' orbitopathy with unilateral upper eyelid retraction.
    Byun JS; Lee JK
    Graefes Arch Clin Exp Ophthalmol; 2018 Oct; 256(10):2001-2008. PubMed ID: 29959506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphometric analysis of eyelid fissure in patients with eyelid retraction in acute stage of dysthyroid orbitopathy after treatment with botulinum toxin type A].
    Costa PG; Saraiva FP; Pereira IC; Matayoshi S
    Arq Bras Oftalmol; 2008; 71(4):480-5. PubMed ID: 18797654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Elongation of the levator palpebrae superioris in palpebral retraction in Basedow's disease].
    Dufour V; Ernst S; Montard M
    J Fr Ophtalmol; 1993; 16(6-7):415-6. PubMed ID: 8360427
    [No Abstract]   [Full Text] [Related]  

  • 14. Surgical method and results of levator aponeurosis transposition for Graves' eyelid retraction.
    Khan JA; Garden V; Faghihi M; Parvin M
    Ophthalmic Surg Lasers; 2002; 33(1):79-82. PubMed ID: 11820671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levator Muscle Enlargement in Thyroid Eye Disease-Related Upper Eyelid Retraction.
    Davies MJ; Dolman PJ
    Ophthalmic Plast Reconstr Surg; 2017; 33(1):35-39. PubMed ID: 26808176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Palpebral asymmetry and Graves' ophthalmopathy].
    Laloux P; Mourain S; Buysschaert M
    Acta Neurol Belg; 1987; 87(5):273-80. PubMed ID: 3434199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves' ophthalmopathy: V. Aetiology of upper eyelid retraction in Graves' ophthalmopathy.
    Feldon SE; Levin L
    Br J Ophthalmol; 1990 Aug; 74(8):484-5. PubMed ID: 2390525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of eyelid retraction by cautery.
    Colla B; Seynaeve L; Dralands G
    Bull Soc Belge Ophtalmol; 1993; 249():95-100. PubMed ID: 7952356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin treatment for upper lid retraction of dysthyroidism.
    Chuenkongkaew W
    J Med Assoc Thai; 2003 Nov; 86(11):1051-4. PubMed ID: 14696787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified levator aponeurosis recession for upper eyelid retraction in Graves' disease.
    Harvey JT; Corin S; Nixon D; Veloudios A
    Ophthalmic Surg; 1991 Jun; 22(6):313-7. PubMed ID: 1896166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.